• Klaria Pharma Holding held an extraordinary general meeting on Oct. 5, 2026.
• Shareholders unanimously adopted a rights offering of up to 61,494,038 units at SEK 2.40 per unit.
• Offering terms set record date Oct. 12, 2026; subscription window Oct. 14–28, 2026; execution remains subject to subscriptions.
• Full take-up would add 245,976,152 shares; full warrant exercise would add a further 61,494,038 shares.
• Meeting also unanimously amended share capital and share-count limits, and authorized up to 4,600,000 units for guarantee compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 20261005:BIT:9129:0) on October 05, 2026, and is solely responsible for the information contained therein.